February 5, 2019

Mapping Merck: A map for Selling to Merck & Co.

Merck & Co. is an American pharmaceutical company, ranked 4th internationally in the world in terms of 2017 prescription sales [1]. It is important to note that Merck & Co. is a wholly separate and independent company from the German company Merck KGaA, despite the fact that the two share a common origin and brand name.

January 14, 2019

Anything but Generic: A map for Selling to Teva Pharmaceuticals

The latest edition of the Sponsor Atlas series takes a look at Israel's generics giant, Teva Pharmaceuticals.

November 14, 2018

Navigating Novo: A Map for Selling to Novo Nordisk

Born from the 1989 merger between Denmark’s top two insulin producers, Novo Nordisk markets products to over 165 countries. Learn how and where they make decisions about outsourcing activities in clinical research, contract manufacturing, logistics, and more.

October 15, 2018

From A to Z: A map for Selling to AstraZeneca

The latest edition of our Sponsor Atlas: Selling to the Pharma Giants series, where we are taking a look at AstraZeneca.

August 20, 2018

Breaking into Bristol, Myers, AND Squibb: A map for Selling to Bristol-Myers Squibb

In this edition of Sponsor Atlas: Selling to the Pharma Giants, we're visiting New York City's biopharma behemoth, Bristol-Myers Squibb (BMS). Their three-part name was born in 1989 merger between the Squibb Corporation and the Bristol-Myers Corporation, two NYC-based pharmaceutical companies founded in 1858 and 1887, respectively.

July 23, 2018

Started From Aspirin™, Now They’re Here: A map for Selling to Bayer

Part 2 of our Sponsor Atlas: Selling to the Pharma Giants blog series. It's off to Germany for the latest stop on our expedition, to visit Bayer and understand how they make their outsourcing decisions and how best to find opportunities.

May 16, 2018

Can I still cold email European pharma companies under GDPR?

A guide to GDPR for service provider companies selling to pharmaceutical & biotech companies in Europe. With strict new regulations being implemented, how can you reach your potential customers?

May 15, 2018

Decisions, Decisions: A map for Selling to Novartis

Multinational giants like Novartis can be a tough sell for service provider companies when they don't know where to target. Understanding where decisions about different kinds of outsourced activities take place can help you close more new business. Join us for part one of our new series Sponsor Atlas: Selling to the Pharma Giants!